Alzheimer disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• APOE 16
• MAPT 2
• APP 1
• NRF2 0
• NLRP3 0
• TREM2 0
• AKT 0
• TDP-43 2
• BDNF 0
• PI3K 0
• BACE1 0
• GLP-1 1
• MAPK 0
• PPAR 0
• AMPK 0
• mTOR 0
• PSEN1 1
• STING 0
• ERK 0
• NMDA 1
• SNCA 0
• TLR4 0
• JNK 0
• SIRT1 0
• CTNNB1 0
• STAT3 0
• TP53 0
• TNF 0
• HDAC 0
• HIF-1 0
• SGLT2 0
• HMGB1 0
• GPX4 0
• IL-1 0
• PCSK9 0
• COX-2 0
• HSP90 1
• C9orf72 0
• DPP-4 0
• PINK1 0
• IL-17 0
• TFEB 0
• IL-6 0
• PD-L1 0
• VEGF 0
• YAP 0
• AQP4 0
• CD33 0
• IGF1R 0
• MMP-9 0
• CCR5 0
• EGFR 0
• FTO 0
• GBA1 0
• GIP 0
• JAK 0
• KEAP1 0
• PARP 0
• PD-1 0
• ACE2 0

EU-13 is a filter, not a ranking: it only narrows the list.

2 of 2+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 86
• Organoids 36
• Mendelian Randomization Analysis 136
• CRISPR-Cas Systems 24
• Gene Expression Profiling 175
• Sequence Analysis, RNA 20
• Whole Genome Sequencing 17
• Exome Sequencing 7
• Proteomics 228
• Metabolomics 81
• Mass Spectrometry 62
• Flow Cytometry 16
• Immunohistochemistry 74
• Liquid Biopsy 5
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 672
• Magnetic Resonance Imaging 992
• Machine Learning 253
• Deep Learning 166
• Cohort Studies 533
• Genome-Wide Association Study 215

• Single-cell machine learning uncovers genetically anchored, cell-type specific programs of Alzheimer's disease.

  Nat Commun, Nov 2026

• In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity.

  Hum Mutat, Nov 2026

• Brain Region-Specific Peptide and Proteomic Signatures Inform Alzheimer's Disease Biomarker Panels.

  J Proteome Res, Nov 2026

• Super-Cross-Reactive Recognition Enables Preclinical Diagnosis of Alzheimer's Disease.

  J Am Chem Soc, Oct 2026

• Explainable machine learning for identifying high-risk Alzheimer's disease and key health characteristics among community-dwelling adults.

  Front Public Health, Oct 2026

• Single-cell, spatial, and machine learning analyses identify ANKIB1 as an oligodendrocyte-anchored palmitoylation-associated candidate biomarker of Alzheimer's disease.

  Transl Psychiatry, Oct 2026

• Advances in artificial intelligence-driven MRI research in Alzheimer's disease.

  Front Neurol, Oct 2026

• A model of brain function to predict tau across Alzheimer's disease and related disorders.

  Nat Commun, Oct 2026

• The application progress of artificial intelligence in the diagnosis of Alzheimer's disease.

  Front Neurol, Oct 2026

• EEG-based brain effective and functional connectivity predict PET-defined amyloid positivity in cognitively normal individuals.

  Alzheimers Dement, Oct 2026

See which targets of this disease your abstract mentions, and go to the people working on them.